partial least squares discriminant analysis pls da models (Umetrics)
Structured Review

Partial Least Squares Discriminant Analysis Pls Da Models, supplied by Umetrics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/partial+least-squares+discrimination+analysis+(pls-da)/1+14+simca/pmc12812765-108-9-16
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "NMR-based urinary biomarkers in pediatric primary mitochondrial disorders and chronic kidney disease: shared mitochondrial dysfunction, diverging biosignatures"
Article Title: NMR-based urinary biomarkers in pediatric primary mitochondrial disorders and chronic kidney disease: shared mitochondrial dysfunction, diverging biosignatures
Journal: Metabolomics
doi: 10.1007/s11306-025-02363-8
Figure Legend Snippet: Multivariate analysis of urinary ¹H NMR metabolomic profiles across groups: Primary Mitochondrial Disease (PMD, orange), Suspected Mitochondrial Disease (SMD, yellow), Control individuals (green), Chronic Kidney Disease (CKD) stages 1–2 (lilac) and stages 3–5 (purple). The ellipses represent 95% confidence intervals. A Principal Component Analysis (PCA) highlights distinct metabolic fingerprint in CKD patients compared to other groups. B Corresponding supervised model using partial least squares discriminant analysis (PLS-DA) shows metabolic divergence between groups, particularly between PMD, CKD3-5, and controls. PMD primary mitochondrial disease, SMD suspected mitochondrial dysfunction, CKD chronic kidney disease
Techniques Used: Metabolomic, Control
Figure Legend Snippet: Supervised multivariate models and spectral features associated with mitochondrial disorders. I. Partial Least Squares Discriminant Analysis (PLS-DA) models were generated to compare patients with PMD to: A controls, B SMD, C . CKD stages 1–2, and D . CKD stages 3–5. The corresponding Q² values, indicate the predictive performance of each model. Clear discrimination was observed between PMD and controls (Q² = 0.53), and both CKD subgroups (Q² = 0.62 and 0.78). In contrast, the model comparing PMD to SMD showed lower predictive performance (Q² = 0.25), reflecting significant metabolic overlap. II. Corresponding loadings plot of model A, color-coded by variable importance in projection (VIP) scores for the first latent variable (LV1) highlighting spectral regions that contribute most to the separation between PMD and controls. (regions around 1.2–2.5 ppm and 3.0–4.5 ppm, consistent with metabolites involved in amino acid metabolism, organic acids, and energy-related pathways). Three-letter code used for amino acids. Abbreviations: 3-HBA: 3-hydroxybutyrate; 4-HPA: 4-hydroxyphenylacetate; N -PhAcGly: N -phenylacetylglycine. Ui: resonances at chemical shift i, which remain unassigned (or with tentative assignment)
Techniques Used: Generated
Related Articles
other:Article Title: Metabolomics strategy assisted by transcriptomics analysis to identify biomarkers associated with schizophrenia. Article Snippet: Metabolomics strategy was applied to select the novel biomarkers associated with schizophrenia under the aid of transcriptomics analysis. a-CEHC, neuraminic acid, glyceraldehyde and asparagine were identified and used to establish the diagnostic panel.. The diagnostic model had better performance in distinguishing schizophrenia patients from healthy people than traditional method (WHO-DAS score). a r t i c l e i n f o Article Title: Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis Article Snippet: Partial least squares-discrimination analysis (PLS-DA) and orthagonal partial least squares-discrimination analysis (OPLS-DA) were performed using MetaboAnalyst v4.0 or Article Title: Identifying the Novel Gut Microbial Metabolite Contributing to Metabolic Syndrome in Children Based on Integrative Analyses of Microbiome-Metabolome Signatures. Article Snippet: A supervised model of partial least-squares discrimination analysis (PLS-DA) was applied to assess the metabolic alterations among groups in Article Title: PD n-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function Article Snippet: Partial least squares-discrimination analysis (PLS-DA) and principal component analysis (PCA) (Janes and Yaffe, 2006) were performed using Article Title: Qing-Luo-Yin Alleviated Experimental Arthritis in Rats by Disrupting Immune Feedback Between Inflammatory T Cells and Monocytes: Key Evidences from Its Effects on Immune Cell Phenotypes Article Snippet: Partial least squares-discrimination analysis (PLS-DA) and corresponding seven-fold cross-validation were performed using Article Title: Triacylglycerols in human milk and their association with edible oils in maternal diet: A study of five regions in China Article Snippet: Triacylglycerol (TAG) is the predominant lipid in human milk fat (~98 %).. The association between TAG and maternal diet is interesting but barely understood.. In this study, we analyzed the TAG composition in human milk of mothers consuming seven edible oils during three lactation stages in five cities in China. Article Title: Identifying the Novel Gut Microbial Metabolite Contributing to Metabolic Syndrome in Children Based on Integrative Analyses of Microbiome-Metabolome Signatures Article Snippet: A supervised model of partial least-squares discrimination analysis (PLS-DA) was applied to assess the metabolic alterations among groups in |